ALPS Medical Breakthroughs ETF (SBIO) |
| 53.85 -1.19 (-2.16%) 10-12 16:00 |
| Open: | 54.855 |
| High: | 55.025 |
| Low: | 53.74 |
| Volume: | 22,694 |
| Market Cap: | 171(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 67.35 |
| Resistance 1: | 61.70 |
| Pivot price: | 56.92 |
| Support 1: | 52.57 |
| Support 2: | 43.74 |
| 52w High: | 70.85 |
| 52w Low: | 40.57 |
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 09 Oct 2026
ALPS Medical Breakthroughs ETF (SBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sat, 03 Oct 2026
Why (SBIO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wed, 23 Sep 2026
Behavioral Patterns of SBIO and Institutional Flows - Stock Traders Daily
Tue, 22 Sep 2026
SBIO: Big Pharma Needs What This Fund Owns (NYSEARCA:SBIO) - Seeking Alpha
Tue, 08 Sep 2026
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)? - Yahoo Finance
Thu, 09 Jul 2026
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
